Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation.
Lim S, Hong SJ, Kim JH, Cha JJ, Joo HJ, Park JH, Yu CW, Kim BK, Chang K, Park Y, Song YB, Ahn SG, Suh JW, Lee SY, Cho JR, Her AY, Jeong YH, Kim HS, Kim MH, Shin ES, Lim DS; PTRG Investigators. Lim S, et al. Among authors: kim bk, kim hs, kim mh, kim jh. Sci Rep. 2024 Jan 4;14(1):520. doi: 10.1038/s41598-023-50920-9. Sci Rep. 2024. PMID: 38177178 Free PMC article.
Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans.
Suh JW, Park JS, Cho HJ, Kim MS, Kang HJ, Cho YS, Koo BK, Chung WY, Youn TJ, Chae IH, Choi DJ, Kim HS, Sohn DW, Oh BH, Park YB. Suh JW, et al. Among authors: kim ms, kim hs. Int J Cardiol. 2007 Apr 12;117(1):31-6. doi: 10.1016/j.ijcard.2006.03.009. Epub 2007 Feb 8. Int J Cardiol. 2007. PMID: 17292498 Clinical Trial.
A prominent coronary Thebesian system.
Park KW, Kim YJ, Kim HS. Park KW, et al. Among authors: kim yj, kim hs. Eur Heart J. 2007 Oct;28(20):2448. doi: 10.1093/eurheartj/ehm190. Epub 2007 Jun 3. Eur Heart J. 2007. PMID: 17548340 No abstract available.
Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
Hahn JY, Cho HJ, Kang HJ, Kim TS, Kim MH, Chung JH, Bae JW, Oh BH, Park YB, Kim HS. Hahn JY, et al. Among authors: kim ts, kim mh, kim hs. J Am Coll Cardiol. 2008 Mar 4;51(9):933-43. doi: 10.1016/j.jacc.2007.11.040. J Am Coll Cardiol. 2008. PMID: 18308163 Free article. Clinical Trial.
16,157 results
You have reached the last available page of results. Please see the User Guide for more information.